US20140163586A1 - Tissue repair devices and methods - Google Patents

Tissue repair devices and methods Download PDF

Info

Publication number
US20140163586A1
US20140163586A1 US13/796,607 US201313796607A US2014163586A1 US 20140163586 A1 US20140163586 A1 US 20140163586A1 US 201313796607 A US201313796607 A US 201313796607A US 2014163586 A1 US2014163586 A1 US 2014163586A1
Authority
US
United States
Prior art keywords
tissue
coil
repair device
elongate
tissue repair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/796,607
Inventor
Dolly Jeanne Holt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novabio Technologies LLC
Original Assignee
Dolly Jeanne Holt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dolly Jeanne Holt filed Critical Dolly Jeanne Holt
Priority to US13/796,607 priority Critical patent/US20140163586A1/en
Priority to EP13863287.2A priority patent/EP2931140A4/en
Priority to PCT/US2013/064568 priority patent/WO2014092855A1/en
Publication of US20140163586A1 publication Critical patent/US20140163586A1/en
Assigned to NOVABIO TECHNOLOGIES, LLC reassignment NOVABIO TECHNOLOGIES, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HOLT, Dolly Jeanne
Priority to US17/465,464 priority patent/US20220054133A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/08Muscles; Tendons; Ligaments
    • A61F2/0811Fixation devices for tendons or ligaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A61B17/083Clips, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B17/1146Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis of tendons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B17/1114Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis of the digestive tract, e.g. bowels or oesophagus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B17/1128Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis of nerves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/122Clamps or clips, e.g. for the umbilical cord
    • A61B17/1227Spring clips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0649Coils or spirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1103Approximator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1107Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis for blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1132End-to-end connections

Definitions

  • This disclosure relates generally to the field of surgery. More particularly it relates to devices and methods to support weak tissue or for moving two regions of tissue towards each other to reconnect or support tissue that is separated or at risk of separation.
  • FIG. 1A is a perspective view of a tissue repair device, according to one embodiment of the present disclosure.
  • FIG. 1B is a side view of a tissue repair device, according to one embodiment, in a relaxed state.
  • FIG. 1C is a side view of a tissue repair device, according to one embodiment, in an extended state and having a decreased coil diameter upon extension.
  • FIG. 2 is a side view of a tissue repair device, according to one embodiment, encircling severed or injured tissue.
  • FIG. 3 is illustrates tension distribution within a tissue repair device during extension, in which tension is distributed circumferentially and alleviates tension at the wounded site of the tissue.
  • FIG. 4 illustrates a side view of a tissue repair device, according to one embodiment, encapsulating frayed tissue.
  • FIG. 5 is a perspective view of a tissue repair device, according to another embodiment, having a larger diameter at a first end of the device and a smaller diameter at an opposite second end of the device.
  • FIG. 6 is a perspective view of a tissue repair device, according to another embodiment, having a smaller diameter at a center portion and larger diameters towards each end.
  • FIG. 7 is a perspective view of a tissue repair device, according to another embodiment, having a larger diameter at a center portion and smaller diameters towards each end.
  • FIG. 8 shows various shaped transverse cross-sectional areas of a coil member of a tissue repair device.
  • FIG. 9 shows transverse cross-sectional views of various tissue repair devices, illustrating varying shaped lumens of tissue repair devices.
  • FIGS. 10A-10D are cross-sectional views of various embodiments of a coil member of a tissue repair device, showing the coil member with a macro or micro texture on all or part of a surface.
  • FIGS. 11A-11D are cross-sectional views of a coil member of various embodiments of a tissue repair device, showing the coil member with a coating on all or part of a surface.
  • FIG. 12A is a side view of a tissue repair device encircling and engaged with an elongate tissue.
  • FIG. 12B is a side view of the tissue repair device of FIG. 12A in an extended state engaging the elongate tissue is it is extended.
  • FIG. 13A illustrates deployment of a tissue repair device onto a partial or full tissue tear of an elongate tissue by twisting the coil onto the elongate tissue.
  • FIG. 13B illustrates the tissue repair device of FIG. 13A positioned in place on injured elongate tissue.
  • FIG. 13C illustrates the healed elongate tissue after the tissue repair device dissolves or is removed.
  • FIG. 14A illustrates deployment of a tissue repair device by reversing the twist in the coil, to increase a diameter of the turns of the coil to more easily place the injured elongate tissue within a lumen of the coil.
  • FIG. 14B illustrates the tissue repair device of FIG. 14A in place on the injured elongate tissue.
  • FIG. 14C illustrates the healed tissue after the tissue repair device dissolves or is removed.
  • FIG. 15A illustrates a method of connecting sutures to either end of a severed elongate tissue and threading the sutures through a tissue repair device.
  • FIG. 15B illustrates the injured elongate tissue pulled through the tissue repair device of FIG. 15A using the sutures.
  • FIG. 15C illustrates the injured tissue in place within the tissue repair device of FIG. 15A .
  • FIG. 16 is a flow diagram of a manufacturing process for producing a tissue repair device, according to one embodiment, by using an injection molding system.
  • FIG. 17 is a flow diagram of a manufacturing process for producing a tissue repair device, according to one embodiment, by wrapping an extruded polymer around a heated dowel or heating the polymer and wrapping it around a dowel.
  • FIG. 18 is a flow diagram of a manufacturing process for producing a tissue repair device, according to one embodiment, by wrapping metal around a heated dowel or heating the metal and wrapping it around a dowel.
  • Soft tissue injuries such as lacerations of ligaments and tendons can be repaired using sutures.
  • tissue when the tissue is under stress such as tensile stress, high tension can result at discrete suture sites and cause sutures to tear through the tissue. Torn tissue can require a repeat surgery to be repaired.
  • the disclosed tissue repair devices can be used to effectively ligate and/or support torn or otherwise damaged tissue. The disclosed tissue repair devices distribute tension along repaired tissue and thus decrease the risk of injured tissue being torn after repair.
  • Soft tissue tears such as tears of the Patellar and Achilles tendon rupture, can result in “mop ends” or frayed edges at the torn ends. These frayed ends can be time consuming and difficult to suture together, particularly in a manner to promote healing of the tear.
  • the disclosed tissue repair devices can gather frayed mop ends and promote healing.
  • the disclosed tissue repair devices and methods can also be used to connect or support other elongate tissue within the body such as nerves and blood vessels. Sutures injure tissue in order to remain fixed in place.
  • the disclosed tissue repair devices and methods of treatment can connect or support weak, damaged, or severed tissue while causing minimal or no damage to the tissue.
  • the present disclosure provides tissue repair devices for recombining, reconnecting and/or supporting torn, damaged or weak tissue.
  • the disclosed devices can be used on elongate, slender tissue such as ligaments, tendons, nerves, vessels, intestines, muscles, bones, appendages and any other elongate tissue within the body.
  • the devices can be used in both humans and animals.
  • the present disclosure also provides methods for recombining, reconnecting or supporting torn, damaged or weak tissue, including administering the disclosed devices onto damaged tissue.
  • the present disclosure also provides manufacturing processes for the creation of a device to reconnect damaged tissue.
  • the disclosed embodiments offer improved distribution of tension compared to sutures to prevent tissue from tearing under stress.
  • the disclosed embodiments do not need to pierce the tissue to remain in place.
  • the disclosed embodiments may reconnect or support tissue that is separated or at risk of separation.
  • the disclosed embodiments decrease tension at the wound site by distributing tension along the device and alleviating direct tension on the tissue.
  • the disclosed embodiments can encircle and engage or grip elongate tissue, using principles of friction and constriction, without causing damage to the tissue, for example, to support the damaged elongate tissue and/or to maintain two separated ends of the elongate tissue in close proximity to one another.
  • the disclosed embodiments can provide mechanical support, stability, and the introduction of biologics such as proteins, cells, and growth factors to injured tissue.
  • the disclosed embodiments may facilitate healing by allowing nutrients and oxygen to diffuse into the tissue through the gaps in the coils.
  • the disclosed embodiments may be porous, drug-eluting, and/or otherwise enhanced to promote tissue regeneration and cellular growth of the damaged tissue.
  • the disclosed embodiments may facilitate early mobilization of the injured tissue by stretching and moving with the tissue.
  • the disclosed embodiments may reduce time to repair torn and injured tissue, compared to suturing and other methods.
  • the disclosed embodiments may be used in conjunction with or in place of sutures.
  • the disclosed embodiments can be connected directly to soft tissue, and may not involve mounting to, for example bone, thus, limiting or even preventing any damage to the bone growth plate.
  • the disclosed embodiments may enable tendons or ligaments that become frayed and swollen to be enclosed within a coil to more easily slide within the tight sheath.
  • the disclosed embodiments may also facilitate manipulation of the severed tendon through the sheath during surgery.
  • One embodiment may be connected to soft tissue at a first end and bone at a second end to reduce tension at the soft tissue-bone interface.
  • the disclosed embodiments can encapsulate frayed mop ends of a ligament or tendon, thus reducing the need for complex suturing and decreasing risk of scar adhesion within the tissue sheath.
  • the disclosed embodiments can constrict upon a suture site so that the tendons can glide more readily within the sheath.
  • the disclosed embodiments may allow soft tissue to press up or outward between the coils, creating multiple catch points to inhibit or even prevent the tissue from slipping within the coil.
  • the disclosed embodiments may decrease in diameter upon extension, constricting on the elongate tissue and remaining in place even during extension.
  • a lumen through the device may decrease in diameter upon extension. This decrease in diameter upon extension, can accommodate the decrease in diameter of elongate tissue that may occur when the elongate tissue is extended, thus allowing the device to maintain proper contact and engagement during extension and relaxation of the elongate tissue.
  • the disclosed embodiments may employ principles of friction and constriction to remain in place and maintain contact with injured tissue.
  • the disclosed embodiments may increase in diameter during relaxed states, allowing for the least constriction and maximum diffusion of nutrients to the damaged tissue within the device.
  • the disclosed embodiments can be made of biodegradable polymers that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state.
  • polymers and constituents of co-polymers that can be used are polycaprolactone, polyurethane, polylactic acid, polyglycolic acid, polyvinyl alcohol, polyvinylpyrrolidone, polyester, and poly(hydroxyalkanoate).
  • the disclosed embodiments can be made of naturally biodegradeable materials that can be broken down by the body after the injured tissue is healed, allowing the native tissue to return to its normal state.
  • natural materials that can be used are extracellular matrix proteins such as collagen, fibronectin, fibrinogen, lamanin, elastin, keratin and polysaccharides, such as starch, cellulose, and chitosan.
  • the disclosed embodiments can also be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue.
  • the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body.
  • the disclosed embodiments can be made of non-biodegradable polymers that will remain in place to continue to support the injured tissue.
  • polymers and constituents of co-polymers that can be used are polytetrafluoroethylene, polyurethane, polystyrene, polycarbonate, polyester, polysulfone, polyethylene terephthalate, polyethylene, polypropylene, polyurethane, silicone, polydimethylsiloxane, polymethylmethacrylate, and polyhydroxyethyl methacrylate, and polyetheretherketone.
  • the disclosed embodiments can be made of metals or metal alloys that will remain in place to continue to support the injured tissue.
  • metals or constituents of metal alloys include nitinol, stainless steel, cobalt, chromium, titanium, platinum, iridium, tungsten, tantalum, aluminum, vanadium, molybdenum, silver, copper, silicon, and tin.
  • the disclosed embodiments can be made of metals or metal alloys that can degrade.
  • metals or components in metal alloys that can be used include iron, magnesium, silicon, cobalt, tungsten, boron, carbon, lead, and sulfur.
  • the disclosed embodiments can be made of a ceramic that can be degradable or non-degradable.
  • ceramics include hydroxyapetite, bioglass, calcium phosphate, titanium nitride, tungsten carbide, titanium carbon nitride, aluminas, SiO 2 , Na 2 O, CaO, P 2 O 5 and zirconia.
  • the disclosed embodiments may include deployment during surgery by positioning the open end of the coil at one of the ends onto the tissue and twisting the coil onto the tissue much like twisting a key ring onto a key.
  • the disclosed embodiments may involve twisting the coil onto the ligament or tendon, which may allow the device to be deployed at a site of a partial tear and complete tear of the injured elongate tissue.
  • the disclosed embodiments may include deployment during surgery by suturing each end of the severed tissue and using the sutures to pull the tissue into the lumen of the coiled device.
  • the disclosed embodiments may include deployment by reversing the coil of the device to increase the diameter of the coil to more easily allow insertion of wounded tissue.
  • the presently disclosed embodiments of devices may be created using injection molding processes.
  • the presently disclosed embodiments of devices can be created by wrapping extruded polymer around a dowel.
  • the presently disclosed embodiments of devices can be created by wrapping metal around a dowel.
  • FIG. 1A is a perspective view of a tissue repair device 100 , according to one embodiment.
  • the tissue repair device 100 comprises a coil or spiral shape formed by a coil member 103 arranged in a coil or spiral to form a plurality of interconnected turns 106 that creates a lumen 105 at its center.
  • the tissue repair device 100 can have a length of X and spacing of Y between the turns 106 of the coil 105 of the device 100 .
  • the spacing Y between the turns 106 can vary along the length X of the tissue repair device 100 .
  • the coil member 103 has a thickness Z, which can vary along the length X of the device 100 .
  • FIG. 1B shows a tissue repair device 100 , according to one embodiment, in a relaxed state in which the coil has a first (relaxed) coil diameter W R and a first relaxed length X R .
  • FIG. 1C shows the tissue repair device 100 of FIG. 1B in an extended state and illustrates a resultant decrease in coil diameter W, to a second (extended) coil diameter W E and an extended length X E , as seen compared to the relaxed coil diameter W R and relaxed coil length X R .
  • the tissue repair device 100 may approximate or function in a manner similar to a “Chinese finger trap” in concept by reducing in diameter upon extension, allowing the device to accommodate any decrease in diameter seen in the elongate tissue such as a ligament or tendon during extension.
  • the coil member 103 may be formed of a biodegradable polymers and/or natural materials that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state.
  • polymers and constituents of co-polymers that can be used are polycaprolactone, polyurethane, polylactic acid, polyglycolic acid, polyvinyl alcohol, polyvinylpyrrolidone, polyester, and poly(hydroxyalkanoate).
  • natural materials that can be used are extracellular matrix proteins such as collagen, fibronectin, fibrinogen, lamanin, elastin, keratin and polysaccharides, such as starch, cellulose, and chitosan.
  • the coil member 103 can be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue.
  • the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body.
  • Portions (or all) of the coil member 103 may be porous.
  • the porosity of the coil member 103 may promote tissue growth and/or cellular in-growth, which may enhance engagement or securement of the tissue repair device 100 relative to the injured tissue and/or surrounding tissue. Porosity of the coil member may also contribute to coil compliance and degradation rate. As will be described below, coating may be employed to enhance or reduce porosity of the coil member 103 .
  • FIG. 2 shows a tissue repair device 200 encircling an injured portion 201 of an elongate tissue 202 .
  • the tissue repair device 200 may employ principles of friction and constriction to maintain engagement with and secure the injured portion 201 of the elongate tissue 202 in place, and to limit slipping of the device 200 along the tissue 202 .
  • the tissue repair device 200 may employ principles of friction and/or constriction to remain fixed in place relative to the elongate tissue 202 . For example, sutures may not be needed to maintain the device 200 in a fixed position relative to the elongate tissue 200 .
  • FIG. 3 shows a tissue repair device 300 , according to one embodiment.
  • the tissue repair device 300 is shown encapsulating injured tissue 304 .
  • the tension of the tissue repair device 300 during extension is equally distributed circumferentially 305 around the device, resulting in constriction of the tissue repair device 300 to engage or grip the elongate tissue.
  • This circumferential tension distribution reduces the risk of tearing tissue that is in contact with the device 300 , particularly compared to sutures having tension highly concentrated at a single site of insertion.
  • the tension in the device 300 (and corresponding constriction of the device 300 ) may be less toward the outside ends 303 and greater at the center 301 of the device 300 .
  • the increased tension at the center of the device 301 alleviates the tension experienced by the injured tissue 304 at its center 302 , reducing the risk of tissue separation and/or tearing of sutures at the injured site.
  • the illustrated tissue repair device 300 may be used in conjunction or in lieu of sutures to connect together injured tissue, such as free (or separated) ends of torn (or partially torn) elongate tissue.
  • FIG. 4 shows a tissue repair device 401 enclosing or encircling frayed ends 402 of an elongate tissue 400 circumferentially.
  • the illustrated tissue repair device 401 can gather frayed ends 402 by encapsulation, removing a need for complex suturing to gather the frayed ends.
  • the frayed ends 402 are gathered within a lumen of the tissue repair device.
  • the tissue repair device 401 may maintain the frayed ends 402 in close proximity to one another to facilitate and enhance healing of the elongate tissue 400 .
  • FIG. 5 shows a tissue repair device 500 , according to another embodiment.
  • the illustrated tissue repair device 500 may have a larger coil diameter W 1 on a first end 501 of the device 500 that can be varied by A and a smaller diameter W 2 at a second opposing end 502 that can be varied by B. This design may accommodate changes in a diameter of the tissue along its length X.
  • FIG. 6 shows a tissue repair device 600 , according to another embodiment.
  • the illustrated tissue repair device 600 may have a smaller coil diameter W 1 towards a center portion 603 that can be varied by X and a larger coil diameter W 2 that can be varied by Y at a first end 601 and the same or different larger coil diameter W 3 that can be varied by Z at an opposing second end 602 .
  • FIG. 7 shows a tissue repair device 700 , according to another embodiment.
  • the illustrated tissue repair device may have a larger coil diameter W 1 that can be varied by X at a center portion 703 of the device 700 and a smaller coil diameter W 2 that can be varied by Y at a first end 701 and the same or different smaller coil diameter W 3 that can be varied by Z at the opposing second end 702 .
  • FIG. 8 shows various shaped cross sectional areas 800 - 810 of a coil member (see coil member 103 of FIG. 1 ) of a tissue repair device. Varying cross sectional shapes can be used to maintain the tissue repair device in contact with the tissue and to enable the proper movement of the device within the body. The dimensions of the cross sectional areas 800 - 810 can be altered to best suit the implant situation.
  • the various examples illustrated are merely representative, and are not in any way limiting of the scope of the present disclosure.
  • FIG. 9 shows transverse cross sectional areas 900 - 910 of various tissue repair device, illustrating that varying shaped lumen may be defined by the tissue repair device and can be used to maintain the tissue repair device in contact with the tissue and to enable the proper movement of the device within the body.
  • the dimensions of the cross sectional areas 900 - 910 can be altered to best suit the implant situation.
  • the various examples illustrated are merely representative, and are not in any way limiting of the scope of the present disclosure.
  • FIG. 10A-D shows example magnified cross sectional views of a coil member 1000 , according to various embodiments, to illustrate that the coil member 1000 can be textured on all surfaces 1001 , as shown in FIG. 10A .
  • the texture may provide one of nano-, micro-, meso- and macro-textured surfaces on the coil member 1000 .
  • the coil member 1000 can have texture only along a top surface 1002 or outer surface 1002 , as shown in FIG. 10B , thereby effect (e.g., engaging) the surrounding tissue and environment.
  • the coil member 1000 can have texture only along the bottom surface 1003 , or inner surface 1003 , as seen in FIG. 10C , thereby effect (e.g., engaging) the elongate tissue to be repaired.
  • FIG. 10A-D shows example magnified cross sectional views of a coil member 1000 , according to various embodiments, to illustrate that the coil member 1000 can be textured on all surfaces 1001 , as shown in FIG. 10A .
  • the texture may provide one
  • FIG. 10D shows different texture along the top or outer surface 1004 and the bottom or inner surface 1005 of the coil member 1000 .
  • Textured surfaces can increase surface area, which may enable increased friction and thereby limit slipping of a device of along tissue to be repaired and/or along surrounding tissue.
  • the surface texture may also increase or decrease tissue adhesion as appropriate. Surface texture can be used as appropriate to enhance, or even optimize functionality and ability to repair or support injured tissue.
  • the coil member 1000 may also be smooth, or substantially free of surface texture, on all surfaces.
  • FIG. 11A shows a cross sectional area of the coil member 1100 illustrating the coil member 1000 can include a coating 1101 on all sides 1102 .
  • FIG. 11B shows the coil member 1100 with a coating 1102 only along the top or outer surface that affects the outside of the device or tissue surrounding the device.
  • FIG. 11C shows the coil member 1100 with a coating 1103 only along a bottom or inner surface that affects the inside of the device adjacent to the tissue to be repaired.
  • FIG. 11D shows the coil member 1100 with a coating 1105 along the top our outer surface 1105 and a different coating 1104 along the bottom or inner surface.
  • coatings can comprise altered surface chemistry, chemical coatings, mineral coatings, biological coatings such as proteins, cells, sugars, lipids, etc., and cells such as stem cells, fibroblasts, chondrocytes, epithelial cells, endothelial cells, smooth muscle cells, macrophages, etc. These coatings can assist in cell adhesion, tissue regeneration, and preventing cell adhesion and tissue growth. Coatings can be used to optimize this device's functionality and ability to repair or support injured tissue.
  • the coatings described above may be porous.
  • a porous surface of the coiled member may promote cellular in-growth, which may further stabilize and ensure fixation of the tissue repair device relative to surrounding tissue.
  • the coiled member 1100 itself may be porous and the coating may reduce porosity where cellular in-growth may not be desired.
  • FIG. 12A shows a tissue repair device 1200 , according to one embodiment.
  • the tissue repair device 1200 is disposed around and engaging an elongate tissue 1202 .
  • injured tissue 1203 is shown pressing up (or out) between the turns 1206 of the device 1200 . If a diameter of the device 1200 is smaller than a diameter of the elongate tissue 1202 , then portions of the injured tissue 1203 may press up (or out) between each turn 1206 of the device 1200 .
  • the buckling or pressing up (or out) of the portions of the tissue 1203 between each turn 1206 of the tissue repair device 1200 may create multiple catch points that may prevent the tissue 1202 and device 1200 from sliding relative to each other and/or past one another.
  • FIG. 12B shows the buckling or pressing up of tissue 1203 between each turn 1206 of the device 1200 during extension of the tissue repair device 1200 and elongate tissue 1202 .
  • this construction and buckling may not limit or prevent diffusion of nutrients in the tissue. Also only slight buckling may be sufficient that may not greatly reduce the overall length of the tissue.
  • the tissue to be repaired is a vessel, such as a blood vessel with a hollow lumen, then the diameter of the device can be adjusted so that no buckling of the tissue will occur and the device may be used as a support.
  • FIG. 13A Shows a method of deploying a device 1300 onto tissue 1302 that is partially or fully torn.
  • An end 1306 of the coil member 1303 of the coil device 1300 can be placed on the tissue where there is an open end of the coil 1300 .
  • the device 1300 can be twisted in the direction shown by the arrows 1301 onto the tissue much like a key ring onto a key, twisting the device 1300 , for example one turn 1304 at a time.
  • FIG. 13B shows the device 1300 in place on the injured tissue 1302 .
  • An aspect of the disclosed embodiments is that due to the coiled design, the embodiments can be placed onto tissues that are not completely lacerated, but can be twisted onto partially intact tissue.
  • FIG. 13C shows healed tissue 1305 , after the device 1300 dissolves or is removed.
  • a coil member 1303 of the tissue repair device 1300 may be formed of a biodegradable polymers and/or natural materials that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state.
  • the coil member 1303 can be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue.
  • the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body. Eventually the entire coil member 1303 may break down and/or be absorbed by the body, as shown in FIG. 13C .
  • FIG. 14A shows a method where a device 1400 can be twisted in the reverse direction of the coil member 1403 on either end in order to increase the diameter of the turns of the coil member 1403 , enabling a larger space (lumen 1405 ) to insert the target injured elongate tissue 1402 to be repaired.
  • FIG. 14A illustrate first and second free ends of torn elongate tissue 1402 being inserted into the lumen 1405 of the device 1400 such that the coil member 1403 can constrict around the free ends and draw and or maintain them together in close proximity.
  • FIG. 14B shows the device 1400 in place on injured tissue 1402 .
  • the coil member 1403 , and therefore the lumen 1405 , of the device 1400 is constricted toward the relaxed state in engagement gripping the elongate tissue 1402 .
  • FIG. 14C shows healed tissue 1404 after the device 1400 dissolves or is removed.
  • FIGS. 15A and 15B show a method of threading sutures connected to tissue through a device 1500 .
  • FIG. 15A shows a pair of sutures 1504 that are sutured to each severed end of injured tissue 1502 .
  • the sutures 1504 can be threaded into and/or through a lumen 1505 of a tissue repair device 1500 .
  • FIG. 15B shows a method of threading the available end (or free end) of the sutures 1504 into and through a lumen the device 1500 and pulling the sutures 1504 through the device in order to pull the attached severed tissue 1502 into the device 1500 .
  • FIG. 15C shows severed tissue 1502 within and encircled by the device 1500 .
  • FIG. 16 is a flow diagram of a manufacturing process for producing a device, according to one embodiment, by using an injection molding system.
  • a polymer or other material of manufacture, e.g., metal
  • the polymer is injected into a mold 1601 .
  • the polymer can be modified using physical or chemical processes 1602 .
  • the polymer is allowed to set 1603 .
  • the polymer can be removed from the mold and further modified using physical or chemical processes 1604 .
  • quality assurance testing can be performed on the device 1605 .
  • sterilization and packaging may be performed 1606 .
  • FIG. 17 is a flow diagram of a manufacturing process for producing a device, according to one embodiment of the present disclosure, by wrapping an extruded polymer around a heated dowel or heating the polymer and wrapping it around a heated or non-heated dowel.
  • First the polymer is prepared 1700 by being dissolved, melted, etc.
  • Next the polymer is extruded 1701 .
  • Next the polymer is wrapped around a heated dowel 1702 .
  • the polymer can be heated and wrapped around a heated or non-heated dowel 1702 .
  • the polymer is allowed to set and may be modified using physical or chemical processes 1703 .
  • the polymer may be removed from the dowel 1704 .
  • the polymer may be further modified using physical or chemical processes 1705 .
  • Quality assurance testing may be performed on the device 1706 .
  • Sterilization and packaging may be performed 1707 .
  • FIG. 18 is a flow diagram of a manufacturing process for producing a device, according to the present disclosure, by wrapping metal around a heated dowel or heating the metal and wrapping it around a heated or non-heated dowel.
  • First the metal is prepared 1800 .
  • the metal is wrapped around a heated dowel 1801 .
  • the metal can be heated and wrapped around a heated or non-heated dowel 1801 .
  • the metal is allowed to set and can be subsequently modified using physical or chemical processes 1802 .
  • the metal can be removed from the dowel and further modified using physical or chemical processes 1803 .
  • quality assurance testing can be performed on the device 1804 .
  • sterilization and packaging may be performed 1805 .
  • Additional embodiments include any suitable combination of the features depicted in the drawings. Accordingly, although a specific permutation may not be illustrated as a stand-alone embodiment in any of the drawings, all of the features are shown and described in the drawings such that the present drawings provide full support for these additional embodiments.
  • the disclosed embodiments may comprise a device with a center shape that can accommodate the shape of the tissue to be ligated or supported.
  • These shapes include but are not limited to: circle, elliptical, square, rectangle, triangle trapezoid, or any combination of these shapes that may change shape along the length of the device. For example one end can begin as a circle cross section, but end as an ellipsoid cross section.
  • the disclosed embodiments may use principles of friction and constriction to maintain contact with tissue.
  • the disclosed embodiments may comprise a coil member used to make a coil that can have various shaped cross-sectional areas including circle, elliptical, square, rectangle, triangle trapezoid, etc., or any combination of these shapes and where these shapes can change along the length of the coil member.
  • the disclosed embodiments may comprise a coil member that can be made of varying thicknesses of material that can vary along the length of the device.
  • the device comprises an elongate hollow coiled member of biocompatible, surgically implantable material.
  • the member having a first and second end, with the device being open at both ends.
  • the disclosed embodiments may comprise a method for treating weakened, damaged, and partially or completely lacerated tissue, wherein this method comprises obtaining a tissue repair device and accessing injured tissue within the body.
  • One of the disclosed embodiments may be a method of manufacturing a tissue repair device, comprising: preparing a biocompatible material; forming the biocompatible material into a coil comprising a series of interconnected turns defining a lumen through the coil, the lumen being open at both ends and configured to receive and encircle an elongate tissue to be repaired, wherein the material in a hardened state is configured to allow the coil to be extendable to increase a distance between adjacent turns of the plurality of turns and increase a length of the coil and to decrease a diameter of one or more of the turns of the plurality of turns proportional to extension of the length to more tightly engage an elongate tissue disposed within the lumen to decrease tension at a wound site of the elongate tissue by distributing tension along a length of the coil; and allowing the biocompatible material to set.
  • the method of manufacture may further include texturing an inner surface of the coil to enhance engagement of the inner surface with tissue to be repaired and limit sliding of the tissue repair device relative to the tissue to be repaired.

Abstract

Devices and methods for reconnecting or supporting torn, damaged or weak tissue are disclosed. The disclosed embodiments can be used on long slender tissue such as ligaments, tendons, nerves, vessels, intestines, muscles, bones, appendages and any other elongate tissue within the body, of both humans and other animals. The devices can wrap around elongate tissue and is capable of supporting the tissue or keeping two severed ends in close proximity to one another. The devices can be used in addition to or in lieu of sutures. The devices can function similar to a Chinese Finger Trap and are capable of decreasing in diameter upon extension, thus constricting upon the tissue. The multiple coils of the devices can make sufficient surface contact on the ligament or tendon, using friction to keep the device in place, while also allowing access for diffusion of oxygen and nutrients.

Description

    RELATED APPLICATIONS
  • The present application claims benefit of priority under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 61/736,000, filed Dec. 11, 2012, and entitled “RECOMBINATION AND SUPPORT DEVICES AND METHODS FOR INJURED TISSUE,” which is hereby incorporated herein by reference in its entirety.
  • TECHNICAL FIELD
  • This disclosure relates generally to the field of surgery. More particularly it relates to devices and methods to support weak tissue or for moving two regions of tissue towards each other to reconnect or support tissue that is separated or at risk of separation.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The written disclosure herein describes illustrative embodiments that are non-limiting and non-exhaustive. Reference is made to certain such illustrative embodiments that are depicted in the figures, in which:
  • FIG. 1A is a perspective view of a tissue repair device, according to one embodiment of the present disclosure.
  • FIG. 1B is a side view of a tissue repair device, according to one embodiment, in a relaxed state.
  • FIG. 1C is a side view of a tissue repair device, according to one embodiment, in an extended state and having a decreased coil diameter upon extension.
  • FIG. 2 is a side view of a tissue repair device, according to one embodiment, encircling severed or injured tissue.
  • FIG. 3 is illustrates tension distribution within a tissue repair device during extension, in which tension is distributed circumferentially and alleviates tension at the wounded site of the tissue.
  • FIG. 4 illustrates a side view of a tissue repair device, according to one embodiment, encapsulating frayed tissue.
  • FIG. 5 is a perspective view of a tissue repair device, according to another embodiment, having a larger diameter at a first end of the device and a smaller diameter at an opposite second end of the device.
  • FIG. 6 is a perspective view of a tissue repair device, according to another embodiment, having a smaller diameter at a center portion and larger diameters towards each end.
  • FIG. 7 is a perspective view of a tissue repair device, according to another embodiment, having a larger diameter at a center portion and smaller diameters towards each end.
  • FIG. 8 shows various shaped transverse cross-sectional areas of a coil member of a tissue repair device.
  • FIG. 9 shows transverse cross-sectional views of various tissue repair devices, illustrating varying shaped lumens of tissue repair devices.
  • FIGS. 10A-10D are cross-sectional views of various embodiments of a coil member of a tissue repair device, showing the coil member with a macro or micro texture on all or part of a surface.
  • FIGS. 11A-11D are cross-sectional views of a coil member of various embodiments of a tissue repair device, showing the coil member with a coating on all or part of a surface.
  • FIG. 12A is a side view of a tissue repair device encircling and engaged with an elongate tissue.
  • FIG. 12B is a side view of the tissue repair device of FIG. 12A in an extended state engaging the elongate tissue is it is extended.
  • FIG. 13A illustrates deployment of a tissue repair device onto a partial or full tissue tear of an elongate tissue by twisting the coil onto the elongate tissue.
  • FIG. 13B illustrates the tissue repair device of FIG. 13A positioned in place on injured elongate tissue.
  • FIG. 13C illustrates the healed elongate tissue after the tissue repair device dissolves or is removed.
  • FIG. 14A illustrates deployment of a tissue repair device by reversing the twist in the coil, to increase a diameter of the turns of the coil to more easily place the injured elongate tissue within a lumen of the coil.
  • FIG. 14B illustrates the tissue repair device of FIG. 14A in place on the injured elongate tissue.
  • FIG. 14C illustrates the healed tissue after the tissue repair device dissolves or is removed.
  • FIG. 15A illustrates a method of connecting sutures to either end of a severed elongate tissue and threading the sutures through a tissue repair device.
  • FIG. 15B illustrates the injured elongate tissue pulled through the tissue repair device of FIG. 15A using the sutures.
  • FIG. 15C illustrates the injured tissue in place within the tissue repair device of FIG. 15A.
  • FIG. 16 is a flow diagram of a manufacturing process for producing a tissue repair device, according to one embodiment, by using an injection molding system.
  • FIG. 17 is a flow diagram of a manufacturing process for producing a tissue repair device, according to one embodiment, by wrapping an extruded polymer around a heated dowel or heating the polymer and wrapping it around a dowel.
  • FIG. 18 is a flow diagram of a manufacturing process for producing a tissue repair device, according to one embodiment, by wrapping metal around a heated dowel or heating the metal and wrapping it around a dowel.
  • Other features of the present embodiments will be apparent from the accompanying drawings and from the detailed description that follows.
  • DETAILED DESCRIPTION
  • Soft tissue injuries such as lacerations of ligaments and tendons can be repaired using sutures. However, when the tissue is under stress such as tensile stress, high tension can result at discrete suture sites and cause sutures to tear through the tissue. Torn tissue can require a repeat surgery to be repaired. The disclosed tissue repair devices can be used to effectively ligate and/or support torn or otherwise damaged tissue. The disclosed tissue repair devices distribute tension along repaired tissue and thus decrease the risk of injured tissue being torn after repair.
  • Soft tissue tears, such as tears of the Patellar and Achilles tendon rupture, can result in “mop ends” or frayed edges at the torn ends. These frayed ends can be time consuming and difficult to suture together, particularly in a manner to promote healing of the tear. The disclosed tissue repair devices can gather frayed mop ends and promote healing.
  • The disclosed tissue repair devices and methods can also be used to connect or support other elongate tissue within the body such as nerves and blood vessels. Sutures injure tissue in order to remain fixed in place. The disclosed tissue repair devices and methods of treatment can connect or support weak, damaged, or severed tissue while causing minimal or no damage to the tissue.
  • The present disclosure provides tissue repair devices for recombining, reconnecting and/or supporting torn, damaged or weak tissue. Specifically the disclosed devices can be used on elongate, slender tissue such as ligaments, tendons, nerves, vessels, intestines, muscles, bones, appendages and any other elongate tissue within the body. The devices can be used in both humans and animals. The present disclosure also provides methods for recombining, reconnecting or supporting torn, damaged or weak tissue, including administering the disclosed devices onto damaged tissue. The present disclosure also provides manufacturing processes for the creation of a device to reconnect damaged tissue.
  • The disclosed embodiments offer improved distribution of tension compared to sutures to prevent tissue from tearing under stress.
  • The disclosed embodiments do not need to pierce the tissue to remain in place.
  • The disclosed embodiments may reconnect or support tissue that is separated or at risk of separation.
  • In accordance with the principles of the present disclosure, the disclosed embodiments decrease tension at the wound site by distributing tension along the device and alleviating direct tension on the tissue.
  • The disclosed embodiments can encircle and engage or grip elongate tissue, using principles of friction and constriction, without causing damage to the tissue, for example, to support the damaged elongate tissue and/or to maintain two separated ends of the elongate tissue in close proximity to one another. The disclosed embodiments can provide mechanical support, stability, and the introduction of biologics such as proteins, cells, and growth factors to injured tissue. The disclosed embodiments may facilitate healing by allowing nutrients and oxygen to diffuse into the tissue through the gaps in the coils. For example, the disclosed embodiments may be porous, drug-eluting, and/or otherwise enhanced to promote tissue regeneration and cellular growth of the damaged tissue.
  • The disclosed embodiments may facilitate early mobilization of the injured tissue by stretching and moving with the tissue. The disclosed embodiments may reduce time to repair torn and injured tissue, compared to suturing and other methods. The disclosed embodiments may be used in conjunction with or in place of sutures.
  • The disclosed embodiments can be connected directly to soft tissue, and may not involve mounting to, for example bone, thus, limiting or even preventing any damage to the bone growth plate. The disclosed embodiments may enable tendons or ligaments that become frayed and swollen to be enclosed within a coil to more easily slide within the tight sheath. The disclosed embodiments may also facilitate manipulation of the severed tendon through the sheath during surgery.
  • One embodiment may be connected to soft tissue at a first end and bone at a second end to reduce tension at the soft tissue-bone interface.
  • The disclosed embodiments can encapsulate frayed mop ends of a ligament or tendon, thus reducing the need for complex suturing and decreasing risk of scar adhesion within the tissue sheath.
  • The disclosed embodiments can constrict upon a suture site so that the tendons can glide more readily within the sheath.
  • The disclosed embodiments may allow soft tissue to press up or outward between the coils, creating multiple catch points to inhibit or even prevent the tissue from slipping within the coil.
  • The disclosed embodiments may decrease in diameter upon extension, constricting on the elongate tissue and remaining in place even during extension. In particular, a lumen through the device may decrease in diameter upon extension. This decrease in diameter upon extension, can accommodate the decrease in diameter of elongate tissue that may occur when the elongate tissue is extended, thus allowing the device to maintain proper contact and engagement during extension and relaxation of the elongate tissue. The disclosed embodiments may employ principles of friction and constriction to remain in place and maintain contact with injured tissue.
  • The disclosed embodiments may increase in diameter during relaxed states, allowing for the least constriction and maximum diffusion of nutrients to the damaged tissue within the device.
  • The disclosed embodiments can be made of biodegradable polymers that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state. Examples of polymers and constituents of co-polymers that can be used are polycaprolactone, polyurethane, polylactic acid, polyglycolic acid, polyvinyl alcohol, polyvinylpyrrolidone, polyester, and poly(hydroxyalkanoate).
  • The disclosed embodiments can be made of naturally biodegradeable materials that can be broken down by the body after the injured tissue is healed, allowing the native tissue to return to its normal state. Examples of natural materials that can be used are extracellular matrix proteins such as collagen, fibronectin, fibrinogen, lamanin, elastin, keratin and polysaccharides, such as starch, cellulose, and chitosan.
  • The disclosed embodiments can also be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue. For example, as the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body.
  • The disclosed embodiments can be made of non-biodegradable polymers that will remain in place to continue to support the injured tissue. Examples of polymers and constituents of co-polymers that can be used are polytetrafluoroethylene, polyurethane, polystyrene, polycarbonate, polyester, polysulfone, polyethylene terephthalate, polyethylene, polypropylene, polyurethane, silicone, polydimethylsiloxane, polymethylmethacrylate, and polyhydroxyethyl methacrylate, and polyetheretherketone.
  • The disclosed embodiments can be made of metals or metal alloys that will remain in place to continue to support the injured tissue. Examples of metals or constituents of metal alloys that can be used include nitinol, stainless steel, cobalt, chromium, titanium, platinum, iridium, tungsten, tantalum, aluminum, vanadium, molybdenum, silver, copper, silicon, and tin.
  • The disclosed embodiments can be made of metals or metal alloys that can degrade. Examples of metals or components in metal alloys that can be used include iron, magnesium, silicon, cobalt, tungsten, boron, carbon, lead, and sulfur.
  • The disclosed embodiments can be made of a ceramic that can be degradable or non-degradable. Examples of ceramics include hydroxyapetite, bioglass, calcium phosphate, titanium nitride, tungsten carbide, titanium carbon nitride, aluminas, SiO2, Na2O, CaO, P2O5 and zirconia.
  • The disclosed embodiments may include deployment during surgery by positioning the open end of the coil at one of the ends onto the tissue and twisting the coil onto the tissue much like twisting a key ring onto a key.
  • The disclosed embodiments may involve twisting the coil onto the ligament or tendon, which may allow the device to be deployed at a site of a partial tear and complete tear of the injured elongate tissue.
  • The disclosed embodiments may include deployment during surgery by suturing each end of the severed tissue and using the sutures to pull the tissue into the lumen of the coiled device.
  • The disclosed embodiments may include deployment by reversing the coil of the device to increase the diameter of the coil to more easily allow insertion of wounded tissue.
  • The presently disclosed embodiments of devices may be created using injection molding processes.
  • The presently disclosed embodiments of devices can be created by wrapping extruded polymer around a dowel.
  • The presently disclosed embodiments of devices can be created by wrapping metal around a dowel.
  • Certain embodiments of the present disclosure will now be discussed with reference to the accompanying drawings and reference numerals provided therein so as to enable one skilled in the art to practice the present invention. The drawings and descriptions are examples of various aspects of the invention and are not intended to narrow the scope of the claims to the inventions. Also, for the sake of simplicity, the illustrated devices and tissue may be represented as cylindrical in shape, however each of these embodiments can be altered to accommodate a device and tissue shape that is not cylindrical.
  • FIG. 1A is a perspective view of a tissue repair device 100, according to one embodiment. The tissue repair device 100 comprises a coil or spiral shape formed by a coil member 103 arranged in a coil or spiral to form a plurality of interconnected turns 106 that creates a lumen 105 at its center. The tissue repair device 100 can have a length of X and spacing of Y between the turns 106 of the coil 105 of the device 100. The spacing Y between the turns 106 can vary along the length X of the tissue repair device 100. The coil member 103 has a thickness Z, which can vary along the length X of the device 100. A diameter W of the turns 106 of the coil member 103 can be varied along the length X of the device 100, which correspondingly varies the diameter of the lumen 105. FIG. 1B shows a tissue repair device 100, according to one embodiment, in a relaxed state in which the coil has a first (relaxed) coil diameter WR and a first relaxed length XR. FIG. 1C shows the tissue repair device 100 of FIG. 1B in an extended state and illustrates a resultant decrease in coil diameter W, to a second (extended) coil diameter WE and an extended length XE, as seen compared to the relaxed coil diameter WR and relaxed coil length XR. The tissue repair device 100 may approximate or function in a manner similar to a “Chinese finger trap” in concept by reducing in diameter upon extension, allowing the device to accommodate any decrease in diameter seen in the elongate tissue such as a ligament or tendon during extension.
  • The coil member 103 may be formed of a biodegradable polymers and/or natural materials that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state. Examples of polymers and constituents of co-polymers that can be used are polycaprolactone, polyurethane, polylactic acid, polyglycolic acid, polyvinyl alcohol, polyvinylpyrrolidone, polyester, and poly(hydroxyalkanoate). Examples of natural materials that can be used are extracellular matrix proteins such as collagen, fibronectin, fibrinogen, lamanin, elastin, keratin and polysaccharides, such as starch, cellulose, and chitosan.
  • The coil member 103 can be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue. For example, as the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body.
  • Portions (or all) of the coil member 103 may be porous. The porosity of the coil member 103 may promote tissue growth and/or cellular in-growth, which may enhance engagement or securement of the tissue repair device 100 relative to the injured tissue and/or surrounding tissue. Porosity of the coil member may also contribute to coil compliance and degradation rate. As will be described below, coating may be employed to enhance or reduce porosity of the coil member 103.
  • FIG. 2 shows a tissue repair device 200 encircling an injured portion 201 of an elongate tissue 202. The tissue repair device 200 may employ principles of friction and constriction to maintain engagement with and secure the injured portion 201 of the elongate tissue 202 in place, and to limit slipping of the device 200 along the tissue 202. The tissue repair device 200 may employ principles of friction and/or constriction to remain fixed in place relative to the elongate tissue 202. For example, sutures may not be needed to maintain the device 200 in a fixed position relative to the elongate tissue 200.
  • FIG. 3 shows a tissue repair device 300, according to one embodiment. The tissue repair device 300 is shown encapsulating injured tissue 304. The tension of the tissue repair device 300 during extension is equally distributed circumferentially 305 around the device, resulting in constriction of the tissue repair device 300 to engage or grip the elongate tissue. This circumferential tension distribution reduces the risk of tearing tissue that is in contact with the device 300, particularly compared to sutures having tension highly concentrated at a single site of insertion. The tension in the device 300 (and corresponding constriction of the device 300) may be less toward the outside ends 303 and greater at the center 301 of the device 300. The increased tension at the center of the device 301 alleviates the tension experienced by the injured tissue 304 at its center 302, reducing the risk of tissue separation and/or tearing of sutures at the injured site. The illustrated tissue repair device 300 may be used in conjunction or in lieu of sutures to connect together injured tissue, such as free (or separated) ends of torn (or partially torn) elongate tissue.
  • FIG. 4 shows a tissue repair device 401 enclosing or encircling frayed ends 402 of an elongate tissue 400 circumferentially. The illustrated tissue repair device 401 can gather frayed ends 402 by encapsulation, removing a need for complex suturing to gather the frayed ends. The frayed ends 402 are gathered within a lumen of the tissue repair device. The tissue repair device 401 may maintain the frayed ends 402 in close proximity to one another to facilitate and enhance healing of the elongate tissue 400.
  • FIG. 5 shows a tissue repair device 500, according to another embodiment. The illustrated tissue repair device 500 may have a larger coil diameter W1 on a first end 501 of the device 500 that can be varied by A and a smaller diameter W2 at a second opposing end 502 that can be varied by B. This design may accommodate changes in a diameter of the tissue along its length X.
  • FIG. 6 shows a tissue repair device 600, according to another embodiment. The illustrated tissue repair device 600 may have a smaller coil diameter W1 towards a center portion 603 that can be varied by X and a larger coil diameter W2 that can be varied by Y at a first end 601 and the same or different larger coil diameter W3 that can be varied by Z at an opposing second end 602.
  • FIG. 7 shows a tissue repair device 700, according to another embodiment. The illustrated tissue repair device may have a larger coil diameter W1 that can be varied by X at a center portion 703 of the device 700 and a smaller coil diameter W2 that can be varied by Y at a first end 701 and the same or different smaller coil diameter W3 that can be varied by Z at the opposing second end 702.
  • FIG. 8 shows various shaped cross sectional areas 800-810 of a coil member (see coil member 103 of FIG. 1) of a tissue repair device. Varying cross sectional shapes can be used to maintain the tissue repair device in contact with the tissue and to enable the proper movement of the device within the body. The dimensions of the cross sectional areas 800-810 can be altered to best suit the implant situation. The various examples illustrated are merely representative, and are not in any way limiting of the scope of the present disclosure.
  • FIG. 9 shows transverse cross sectional areas 900-910 of various tissue repair device, illustrating that varying shaped lumen may be defined by the tissue repair device and can be used to maintain the tissue repair device in contact with the tissue and to enable the proper movement of the device within the body. The dimensions of the cross sectional areas 900-910 can be altered to best suit the implant situation. The various examples illustrated are merely representative, and are not in any way limiting of the scope of the present disclosure.
  • FIG. 10A-D shows example magnified cross sectional views of a coil member 1000, according to various embodiments, to illustrate that the coil member 1000 can be textured on all surfaces 1001, as shown in FIG. 10A. The texture may provide one of nano-, micro-, meso- and macro-textured surfaces on the coil member 1000. The coil member 1000 can have texture only along a top surface 1002 or outer surface 1002, as shown in FIG. 10B, thereby effect (e.g., engaging) the surrounding tissue and environment. The coil member 1000 can have texture only along the bottom surface 1003, or inner surface 1003, as seen in FIG. 10C, thereby effect (e.g., engaging) the elongate tissue to be repaired. FIG. 10D shows different texture along the top or outer surface 1004 and the bottom or inner surface 1005 of the coil member 1000. Textured surfaces can increase surface area, which may enable increased friction and thereby limit slipping of a device of along tissue to be repaired and/or along surrounding tissue. The surface texture may also increase or decrease tissue adhesion as appropriate. Surface texture can be used as appropriate to enhance, or even optimize functionality and ability to repair or support injured tissue. The coil member 1000 may also be smooth, or substantially free of surface texture, on all surfaces.
  • FIG. 11A shows a cross sectional area of the coil member 1100 illustrating the coil member 1000 can include a coating 1101 on all sides 1102. FIG. 11B shows the coil member 1100 with a coating 1102 only along the top or outer surface that affects the outside of the device or tissue surrounding the device. FIG. 11C shows the coil member 1100 with a coating 1103 only along a bottom or inner surface that affects the inside of the device adjacent to the tissue to be repaired. FIG. 11D shows the coil member 1100 with a coating 1105 along the top our outer surface 1105 and a different coating 1104 along the bottom or inner surface. The foregoing described coatings can comprise altered surface chemistry, chemical coatings, mineral coatings, biological coatings such as proteins, cells, sugars, lipids, etc., and cells such as stem cells, fibroblasts, chondrocytes, epithelial cells, endothelial cells, smooth muscle cells, macrophages, etc. These coatings can assist in cell adhesion, tissue regeneration, and preventing cell adhesion and tissue growth. Coatings can be used to optimize this device's functionality and ability to repair or support injured tissue.
  • In one embodiment, the coatings described above may be porous. A porous surface of the coiled member may promote cellular in-growth, which may further stabilize and ensure fixation of the tissue repair device relative to surrounding tissue. In another embodiment, the coiled member 1100 itself may be porous and the coating may reduce porosity where cellular in-growth may not be desired.
  • FIG. 12A shows a tissue repair device 1200, according to one embodiment. The tissue repair device 1200 is disposed around and engaging an elongate tissue 1202. In FIG. 12A, injured tissue 1203 is shown pressing up (or out) between the turns 1206 of the device 1200. If a diameter of the device 1200 is smaller than a diameter of the elongate tissue 1202, then portions of the injured tissue 1203 may press up (or out) between each turn 1206 of the device 1200. The buckling or pressing up (or out) of the portions of the tissue 1203 between each turn 1206 of the tissue repair device 1200 may create multiple catch points that may prevent the tissue 1202 and device 1200 from sliding relative to each other and/or past one another.
  • FIG. 12B shows the buckling or pressing up of tissue 1203 between each turn 1206 of the device 1200 during extension of the tissue repair device 1200 and elongate tissue 1202. In the case of ligaments or tendons that do not have vasculature, this construction and buckling may not limit or prevent diffusion of nutrients in the tissue. Also only slight buckling may be sufficient that may not greatly reduce the overall length of the tissue. If the tissue to be repaired is a vessel, such as a blood vessel with a hollow lumen, then the diameter of the device can be adjusted so that no buckling of the tissue will occur and the device may be used as a support.
  • FIG. 13A Shows a method of deploying a device 1300 onto tissue 1302 that is partially or fully torn. An end 1306 of the coil member 1303 of the coil device 1300 can be placed on the tissue where there is an open end of the coil 1300. The device 1300 can be twisted in the direction shown by the arrows 1301 onto the tissue much like a key ring onto a key, twisting the device 1300, for example one turn 1304 at a time. FIG. 13B shows the device 1300 in place on the injured tissue 1302. An aspect of the disclosed embodiments, is that due to the coiled design, the embodiments can be placed onto tissues that are not completely lacerated, but can be twisted onto partially intact tissue. FIG. 13C shows healed tissue 1305, after the device 1300 dissolves or is removed.
  • As described above, a coil member 1303 of the tissue repair device 1300 may be formed of a biodegradable polymers and/or natural materials that can be broken down by the body after the injured tissue is sufficiently healed, allowing the native tissue to return to its normal state. The coil member 1303 can be infused with, or otherwise include nutrients, supplements, medicaments, sugars, growth factors, proteins, and/or hormones, which may promote and enhance healing of the elongate tissue. For example, as the biodegredable polymers and/or natural materials may include elements to promote tissue growth and/or healing that may be released as the biodegradeable polymers and/or natural materials are broken down by the body. Eventually the entire coil member 1303 may break down and/or be absorbed by the body, as shown in FIG. 13C.
  • FIG. 14A shows a method where a device 1400 can be twisted in the reverse direction of the coil member 1403 on either end in order to increase the diameter of the turns of the coil member 1403, enabling a larger space (lumen 1405) to insert the target injured elongate tissue 1402 to be repaired. FIG. 14A illustrate first and second free ends of torn elongate tissue 1402 being inserted into the lumen 1405 of the device 1400 such that the coil member 1403 can constrict around the free ends and draw and or maintain them together in close proximity. FIG. 14B shows the device 1400 in place on injured tissue 1402. The coil member 1403, and therefore the lumen 1405, of the device 1400 is constricted toward the relaxed state in engagement gripping the elongate tissue 1402. FIG. 14C shows healed tissue 1404 after the device 1400 dissolves or is removed.
  • FIGS. 15A and 15B show a method of threading sutures connected to tissue through a device 1500. FIG. 15A shows a pair of sutures 1504 that are sutured to each severed end of injured tissue 1502. The sutures 1504 can be threaded into and/or through a lumen 1505 of a tissue repair device 1500. FIG. 15B shows a method of threading the available end (or free end) of the sutures 1504 into and through a lumen the device 1500 and pulling the sutures 1504 through the device in order to pull the attached severed tissue 1502 into the device 1500. FIG. 15C shows severed tissue 1502 within and encircled by the device 1500.
  • FIG. 16 is a flow diagram of a manufacturing process for producing a device, according to one embodiment, by using an injection molding system. First a polymer (or other material of manufacture, e.g., metal) may be dissolved or melted 1600. Next the polymer is injected into a mold 1601. Next the polymer can be modified using physical or chemical processes 1602. Next the polymer is allowed to set 1603. Next the polymer can be removed from the mold and further modified using physical or chemical processes 1604. Next quality assurance testing can be performed on the device 1605. Lastly, sterilization and packaging may be performed 1606.
  • FIG. 17 is a flow diagram of a manufacturing process for producing a device, according to one embodiment of the present disclosure, by wrapping an extruded polymer around a heated dowel or heating the polymer and wrapping it around a heated or non-heated dowel. First the polymer is prepared 1700 by being dissolved, melted, etc. Next the polymer is extruded 1701. Next the polymer is wrapped around a heated dowel 1702. Alternatively the polymer can be heated and wrapped around a heated or non-heated dowel 1702. Next the polymer is allowed to set and may be modified using physical or chemical processes 1703. The polymer may be removed from the dowel 1704. The polymer may be further modified using physical or chemical processes 1705. Quality assurance testing may be performed on the device 1706. Sterilization and packaging may be performed 1707.
  • FIG. 18 is a flow diagram of a manufacturing process for producing a device, according to the present disclosure, by wrapping metal around a heated dowel or heating the metal and wrapping it around a heated or non-heated dowel. First the metal is prepared 1800. Next the metal is wrapped around a heated dowel 1801. Alternatively the metal can be heated and wrapped around a heated or non-heated dowel 1801. Next the metal is allowed to set and can be subsequently modified using physical or chemical processes 1802. Next the metal can be removed from the dowel and further modified using physical or chemical processes 1803. Next quality assurance testing can be performed on the device 1804. Lastly, sterilization and packaging may be performed 1805.
  • Additional embodiments include any suitable combination of the features depicted in the drawings. Accordingly, although a specific permutation may not be illustrated as a stand-alone embodiment in any of the drawings, all of the features are shown and described in the drawings such that the present drawings provide full support for these additional embodiments.
  • The disclosed embodiments may comprise a device with a center shape that can accommodate the shape of the tissue to be ligated or supported. These shapes include but are not limited to: circle, elliptical, square, rectangle, triangle trapezoid, or any combination of these shapes that may change shape along the length of the device. For example one end can begin as a circle cross section, but end as an ellipsoid cross section.
  • The disclosed embodiments may use the number and tightness of coils to control the grip onto the tissue
  • The disclosed embodiments may use principles of friction and constriction to maintain contact with tissue.
  • The disclosed embodiments may comprise a coil member used to make a coil that can have various shaped cross-sectional areas including circle, elliptical, square, rectangle, triangle trapezoid, etc., or any combination of these shapes and where these shapes can change along the length of the coil member.
  • The disclosed embodiments may comprise a coil member that can be made of varying thicknesses of material that can vary along the length of the device.
  • The disclosed embodiments where the device comprises an elongate hollow coiled member of biocompatible, surgically implantable material. The member having a first and second end, with the device being open at both ends.
  • The disclosed embodiments may comprise a method for treating weakened, damaged, and partially or completely lacerated tissue, wherein this method comprises obtaining a tissue repair device and accessing injured tissue within the body.
  • One of the disclosed embodiments may be a method of manufacturing a tissue repair device, comprising: preparing a biocompatible material; forming the biocompatible material into a coil comprising a series of interconnected turns defining a lumen through the coil, the lumen being open at both ends and configured to receive and encircle an elongate tissue to be repaired, wherein the material in a hardened state is configured to allow the coil to be extendable to increase a distance between adjacent turns of the plurality of turns and increase a length of the coil and to decrease a diameter of one or more of the turns of the plurality of turns proportional to extension of the length to more tightly engage an elongate tissue disposed within the lumen to decrease tension at a wound site of the elongate tissue by distributing tension along a length of the coil; and allowing the biocompatible material to set.
  • The method of manufacture may further include texturing an inner surface of the coil to enhance engagement of the inner surface with tissue to be repaired and limit sliding of the tissue repair device relative to the tissue to be repaired.
  • The examples and embodiments disclosed herein are to be construed as merely illustrative and exemplary, and not a limitation of the scope of the present disclosure in any way. It will be understood to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the disclosure herein. For example, any suitable combination of various embodiments, or the features thereof, is contemplated. For example, any of the devices disclosed herein can include features of other embodiments. The scope of the invention is therefore defined by the following claims and their equivalents.

Claims (29)

What is claimed is:
1. A tissue repair device comprising:
a coil comprising a plurality of interconnected turns in series, the coil formed of an elongate coil member of biocompatible material, the coil member having a first end and a second end and configured in a spiral pattern to form the series of interconnected turns of the coil and define a lumen through the coil, the lumen being open at both ends and configured to receive and encircle an elongate tissue to be repaired, the coil being extendable to increase a distance between adjacent turns of the plurality of turns and increase a length of the coil,
wherein each turn of the plurality of the turns of the coil has a first diameter when the coil is in a relaxed state, the diameter configured to engage the elongate tissue in the relaxed state and configured to reduce to a second diameter smaller than the first diameter when the coil is in an extended state to more tightly engage the elongate tissue,
wherein turns of the coil at a first end of the coil are configured to engage a first portion of the elongate tissue and turns of the coil at a second end of the coil engaging a second portion of the elongate tissue such that a tension on the elongate tissue pulling the first portion in direction away from the second portion of the elongate tissue extends the coil, thereby reducing the diameter of turns of the plurality of turns of the coil member to more tightly engage the elongate tissue and decrease tension at a wound site of the elongate tissue by distributing tension along a length of the coil.
2. The tissue repair device of claim 1, wherein the plurality of turns of the coil member define a lumen configured to receive and encircle an elongate tissue of human and animal origin that is one of a ligament, a tendon, a nerve, a vessel, an intestine, a muscle, an appendage, and a bone.
3. The tissue repair device of claim 1, wherein the lumen has a first open end and a second open end, the first open end being one of circular, elliptical, square, rectangular, triangular, and trapezoidal and the second open end being one of circular, elliptical, square, rectangular, triangular, and trapezoidal.
4. The tissue repair device of claim 1, wherein the elongate coil member is formed of one of a metal, a polymer, and a ceramic.
5. The tissue repair device of claim 1, wherein the coil member is biodegradable.
6. The tissue repair device of claim 5, wherein the coil member further comprises one or more of a medicament and a nutrient to enhance tissue regeneration.
7. The tissue repair device of claim 1, wherein the coil member is drug-eluting to promote tissue regeneration.
8. The tissue repair device of claim 1, wherein the coil member is porous to promote cellular in-growth.
9. The tissue repair device of claim 1, wherein spacing between adjacent turns of the plurality of turns of the coil, in the relaxed state, varies along a length of the coil.
10. The tissue repair device of claim 1, wherein a transverse cross-sectional area of the lumen through the coil varies along a length of the coil.
11. The tissue repair device of claim 1, wherein the cross sectional area of the lumen of the coil at a first end is smaller than at a second end.
12. The tissue repair device of claim 1, wherein the cross sectional area of the lumen of the coil is smaller at a center region of the coil and larger towards ends of the coil.
13. The tissue repair device of claim 1, where the cross sectional area of the lumen of the coil is larger in the center of the coil and smaller towards the two outside ends.
14. The tissue repair device of claim 1, wherein a thickness of the coil member varies along a length of the coil.
15. The tissue repair device of claim 1, wherein a transverse cross-section of the coil member is one of circular, elliptical, square, rectangular, triangular, trapezoidal, or a combination and the second open end being one of circular, elliptical, square, rectangular, triangular, and trapezoidal.
16. The tissue repair device of claim 1, wherein the coil member has one of nano-, micro-, meso- and macro-textured surfaces.
17. The tissue repair device of claim 1, wherein the coil member is coated with a coating comprising one or more of cells, a chemical, a mineral, a natural polymer, a synthetic polymer, a protein, a carbohydrate, and a sugar.
18. The tissue repair device of claim 17, wherein the coating is applied to an inner surface of the coil.
19. The tissue repair device of claim 1, wherein the coil member is formed by wrapping a polymer around a dowel and allowing the polymer to cure.
20. The tissue repair device of claim 1, wherein the coil member is configured to remain engaged around the elongate tissue, with an inner surface of the plurality of turns engaging the elongate member using principles of friction and constriction, independent of sutures through the elongate tissue.
21. A method of supporting tissue, the method comprising:
obtaining a tissue repair device comprising a coil formed by an elongate coil member of biocompatible material having a first end and a second end and configured in a spiral pattern to form a series of interconnected turns and to define a lumen through the coil member being open at both ends to receive, encircle, and engage target elongate tissue to be treated;
accessing within the body the target elongate tissue; and
positioning the tissue repair device with the coil around the target elongate tissue, with the target elongate tissue disposed through the lumen with an inner surface of the series of interconnected turns engaging the target elongate tissue.
22. The method of claim 21, wherein supporting tissue comprises connecting together a first free end and a second free end of a torn elongate tissue, the method further comprising:
drawing together the first free end and the second free end of the torn elongate tissue to be connected, and wherein positioning the tissue repair device includes positioning the first and second free ends to be connected within the lumen with an inner surface of the series of interconnected turns engaging the target elongate tissue and maintaining the first free end and the second free end of the target elongate tissue in close proximity to each other.
23. The method of claim 21, wherein the coil is extendable from a relaxed state to an extended state and each turn of the series of interconnected turns has a first diameter when in a the relaxed state and a second smaller diameter when in the extended state.
24. The method of claim 21, wherein the tissue repair device is configured such that tensile stress on the elongate tissue extends the coil to the extended state and thereby distributes tension resulting from the tensile stress along the target elongate tissue through a length of the coil.
25. The method of claim 21, wherein the tissue repair device is configured such that a first end can be mounted to a bone and a second end can encircle soft tissue and thereby relieve tension at the bone-soft tissue interface.
26. The method of claim 21, wherein positioning the tissue repair device comprises:
engaging a first end of the coil member of the tissue repair device with the target elongate tissue; and
twisting the coil member of the tissue repair device onto the target elongate tissue to position the target elongate tissue through the lumen with an inner surface of the series of interconnected turns engaging the target elongate tissue.
27. The method of claim 21, wherein positioning the tissue repair device comprises:
twisting the coil member in a direction opposite a direction of the spiral pattern to increase a diameter of one or more turns of the series of interconnected turns to allow positioning of the coil around the target elongate tissue, with the injured tissue disposed within the lumen of the tissue repair device and an inner surface of the series of interconnected turns engaging the target elongate tissue.
28. The method of claim 21, wherein positioning the tissue repair device comprises:
attaching sutures to ends of the elongate tissue to be joined and passing a free end of the sutures that are not attached to elongate tissue through the tissue repair device in opposite directions and pulling the ends of the elongate tissue into the tissue repair device.
29. A method of connecting tissue, the method comprising:
obtaining a tissue repair device comprising a coil formed by an elongate coil member of biocompatible material having a first end and a second end and configured in a spiral pattern to form a series of interconnected turns and to define a lumen through the coil member being open at both ends to receive, encircle, and engage target elongate tissue to be treated;
accessing within the body the target elongate tissue;
drawing together a first free end and a second free end of the target elongate tissue to be connected; and
positioning the tissue repair device with the coil around the target elongate tissue with the target elongate tissue, including the first and second free ends to be connected, disposed within the lumen with an inner surface of the series of interconnected turns engaging the target elongate tissue and maintaining the first free end and the second free end of the target elongate tissue in close proximity.
US13/796,607 2012-12-11 2013-03-12 Tissue repair devices and methods Abandoned US20140163586A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/796,607 US20140163586A1 (en) 2012-12-11 2013-03-12 Tissue repair devices and methods
EP13863287.2A EP2931140A4 (en) 2012-12-11 2013-10-11 Tissue repair devices and methods
PCT/US2013/064568 WO2014092855A1 (en) 2012-12-11 2013-10-11 Tissue repair devices and methods
US17/465,464 US20220054133A1 (en) 2012-12-11 2021-09-02 Tissue repair devices and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261736000P 2012-12-11 2012-12-11
US13/796,607 US20140163586A1 (en) 2012-12-11 2013-03-12 Tissue repair devices and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/465,464 Division US20220054133A1 (en) 2012-12-11 2021-09-02 Tissue repair devices and methods

Publications (1)

Publication Number Publication Date
US20140163586A1 true US20140163586A1 (en) 2014-06-12

Family

ID=50881775

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/796,607 Abandoned US20140163586A1 (en) 2012-12-11 2013-03-12 Tissue repair devices and methods
US17/465,464 Pending US20220054133A1 (en) 2012-12-11 2021-09-02 Tissue repair devices and methods

Family Applications After (1)

Application Number Title Priority Date Filing Date
US17/465,464 Pending US20220054133A1 (en) 2012-12-11 2021-09-02 Tissue repair devices and methods

Country Status (3)

Country Link
US (2) US20140163586A1 (en)
EP (1) EP2931140A4 (en)
WO (1) WO2014092855A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170143469A1 (en) * 2014-06-25 2017-05-25 Assistance Publique - Hopitaux De Paris Removable implant for generating a tendon or a ligament
DE102015121374A1 (en) * 2015-12-08 2017-06-08 Otto-Von-Guericke-Universität Magdeburg Clip for the treatment of aneurysms and closure of tubular anatomical structures
US9993332B2 (en) 2014-07-09 2018-06-12 Medos International Sarl Systems and methods for ligament graft preparation
US10383720B2 (en) 2015-12-22 2019-08-20 DePuy Synthes Products, Inc. Graft preparation system
US10433847B2 (en) * 2013-12-17 2019-10-08 The Board Of Regents Of The University Of Nebraska Platform device and method of use to assist in anastomosis formation
US20210121181A1 (en) * 2017-07-26 2021-04-29 Neuraptive Therapeutics, Inc. Device and method of creating a fluid containment field for administering therapeutics to a nerve
US20210338414A1 (en) * 2020-04-30 2021-11-04 Industrial Technology Research Institute Tissue repair device and method for using the same
US11864748B2 (en) 2015-04-23 2024-01-09 Depuy Synthes Products, Inc Knotless suture anchor guide

Citations (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US5191903A (en) * 1991-06-06 1993-03-09 Donohue Patrick T Digital traction system
US5583319A (en) * 1993-10-21 1996-12-10 Lieurance; Dennis W. Low resistance superconductor cable splice and splicing method
US5984896A (en) * 1997-10-28 1999-11-16 Ojp #73, Inc. Fixated catheter
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6171338B1 (en) * 1988-11-10 2001-01-09 Biocon, Oy Biodegradable surgical implants and devices
US6171320B1 (en) * 1996-12-25 2001-01-09 Niti Alloys Technologies Ltd. Surgical clip
US20020010481A1 (en) * 1999-12-23 2002-01-24 Swaminathan Jayaraman Occlusive coil manufacture and delivery
US20030040790A1 (en) * 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US20030040803A1 (en) * 2001-08-23 2003-02-27 Rioux Robert F. Maintaining an open passageway through a body lumen
US20030114920A1 (en) * 1999-12-21 2003-06-19 Caro Colin Gerald Vascular stents
US20030195562A1 (en) * 2002-04-12 2003-10-16 Ethicon, Inc. Suture anchoring and tensioning device and method for using same
US6648911B1 (en) * 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US20040260384A1 (en) * 2003-06-17 2004-12-23 Medtronic Ave Superelastic coiled stent
US20060095058A1 (en) * 2004-10-13 2006-05-04 Protech Medical Technologies Ltd. Prostate treatment stent
US20060142845A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20060212047A1 (en) * 2001-09-06 2006-09-21 Ryan Abbott Systems and Methods for Treating Septal Defects
US20070056591A1 (en) * 2005-09-15 2007-03-15 Mcswain Hugh Fallopian tube occlusion devices and methods
US20070203519A1 (en) * 2006-02-28 2007-08-30 Lorenzo Juan A Embolic device delivery system
US20080004640A1 (en) * 2006-06-28 2008-01-03 Abbott Laboratories Vessel closure device
US20080228146A1 (en) * 2007-03-13 2008-09-18 Yoav Shaked Positioning device for ostial lesions
US20090132031A1 (en) * 2007-11-16 2009-05-21 Medtronic Vascular, Inc. Stent Having Spiral Channel for Drug Delivery
US20090142132A1 (en) * 2007-11-30 2009-06-04 Klein Arnold G Flyline connecting device
US20090157168A1 (en) * 2007-12-18 2009-06-18 Abbott Laboratories Method and apparatus for reducing the size of an endoprosthesis
US20100010514A1 (en) * 2008-07-11 2010-01-14 Olympus Medical Systems Corp. Tissue fastening tool
US20100010293A1 (en) * 2008-07-10 2010-01-14 Olympus Medical Systems Corp. Treatment method
US20100010520A1 (en) * 2008-07-11 2010-01-14 Olympus Medical Systems Corp. Tissue fastener
US20100168841A1 (en) * 2007-01-16 2010-07-01 Furst Joseph G Metal alloys for medical devices
US20100292785A1 (en) * 2007-04-20 2010-11-18 Medtronic Corevalve Llc Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US20120083820A1 (en) * 2009-04-22 2012-04-05 The Regents Of The University Of California Expandable distension device for hollow organ growth
US20120215236A1 (en) * 2010-06-22 2012-08-23 Olympus Medical Systems Corp. Tissue fastner production method and tissue fastener
US20130013065A1 (en) * 2011-07-07 2013-01-10 Matthew Bills Tendon repair device and method
US20130103166A1 (en) * 2011-04-13 2013-04-25 The Quality of Life Plus (QL+) Program Prosthetic Attachment Techniques

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU715082A1 (en) * 1977-01-24 1980-02-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Surgical suturing apparatus
US4300244A (en) * 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
US4881939A (en) * 1985-02-19 1989-11-21 The Johns Hopkins University Implantable helical cuff
US5556428A (en) * 1993-09-29 1996-09-17 Shah; Mrugesh K. Apparatus and method for promoting growth and repair of soft tissue
US6174333B1 (en) * 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
US7611521B2 (en) * 1996-09-13 2009-11-03 Tendon Technology, Ltd. Apparatus and methods for tendon or ligament repair
US6984241B2 (en) * 1996-09-13 2006-01-10 Tendon Technology, Ltd. Apparatus and methods for tendon or ligament repair
US5972001A (en) * 1996-11-25 1999-10-26 Yoon; Inbae Method of ligating anatomical tissue with a suture spring device
US6485503B2 (en) * 2000-05-19 2002-11-26 Coapt Systems, Inc. Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device
JP4581318B2 (en) * 2002-08-09 2010-11-17 ニプロ株式会社 Biodegradable cylindrical body and biological tissue or organ regeneration device using the same
EP1874194A4 (en) * 2005-01-09 2008-12-03 Shifrin Edward G Method and extravenous corrector for simultaneous repair of multiple incompetent venous valves
JP2009039139A (en) * 2005-12-28 2009-02-26 Japan Science & Technology Agency Composite scaffold for tissue regeneration
US20090248142A1 (en) * 2008-03-25 2009-10-01 Medtronic Vascular, Inc. Methods, Devices and Systems for Treating Venous Insufficiency
WO2011091169A1 (en) * 2010-01-20 2011-07-28 University Of Rochester Nerve and blood vessel repair systems
US20110276071A1 (en) * 2010-05-08 2011-11-10 Connor Robert A Vasospasm-reducing aneurysm clip
EP2425799B1 (en) * 2010-09-03 2012-11-07 Tornier, Inc. Surgical device for soft tissue repair and surgical kit including such a device
US9427309B2 (en) * 2012-07-30 2016-08-30 Conextions, Inc. Soft tissue repair devices, systems, and methods
EP2832319A1 (en) * 2013-07-31 2015-02-04 Universitätsklinikum Jena Implant for bundling a plurality of tendons, particularly chordae tendineae
WO2018154504A1 (en) * 2017-02-23 2018-08-30 Valavanis Stratigoula Advanced tendon grasping devices and devices for their application

Patent Citations (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US6171338B1 (en) * 1988-11-10 2001-01-09 Biocon, Oy Biodegradable surgical implants and devices
US5191903A (en) * 1991-06-06 1993-03-09 Donohue Patrick T Digital traction system
US5583319A (en) * 1993-10-21 1996-12-10 Lieurance; Dennis W. Low resistance superconductor cable splice and splicing method
US6171320B1 (en) * 1996-12-25 2001-01-09 Niti Alloys Technologies Ltd. Surgical clip
US5984896A (en) * 1997-10-28 1999-11-16 Ojp #73, Inc. Fixated catheter
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US20030040790A1 (en) * 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US20030114920A1 (en) * 1999-12-21 2003-06-19 Caro Colin Gerald Vascular stents
US20020010481A1 (en) * 1999-12-23 2002-01-24 Swaminathan Jayaraman Occlusive coil manufacture and delivery
US6648911B1 (en) * 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US20030040803A1 (en) * 2001-08-23 2003-02-27 Rioux Robert F. Maintaining an open passageway through a body lumen
US20060212047A1 (en) * 2001-09-06 2006-09-21 Ryan Abbott Systems and Methods for Treating Septal Defects
US20030195562A1 (en) * 2002-04-12 2003-10-16 Ethicon, Inc. Suture anchoring and tensioning device and method for using same
US20040260384A1 (en) * 2003-06-17 2004-12-23 Medtronic Ave Superelastic coiled stent
US20060095058A1 (en) * 2004-10-13 2006-05-04 Protech Medical Technologies Ltd. Prostate treatment stent
US20060142845A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for making same
US20070056591A1 (en) * 2005-09-15 2007-03-15 Mcswain Hugh Fallopian tube occlusion devices and methods
US20070203519A1 (en) * 2006-02-28 2007-08-30 Lorenzo Juan A Embolic device delivery system
US20080004640A1 (en) * 2006-06-28 2008-01-03 Abbott Laboratories Vessel closure device
US20100168841A1 (en) * 2007-01-16 2010-07-01 Furst Joseph G Metal alloys for medical devices
US20080228146A1 (en) * 2007-03-13 2008-09-18 Yoav Shaked Positioning device for ostial lesions
US20100292785A1 (en) * 2007-04-20 2010-11-18 Medtronic Corevalve Llc Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US20090132031A1 (en) * 2007-11-16 2009-05-21 Medtronic Vascular, Inc. Stent Having Spiral Channel for Drug Delivery
US20090142132A1 (en) * 2007-11-30 2009-06-04 Klein Arnold G Flyline connecting device
US20090157168A1 (en) * 2007-12-18 2009-06-18 Abbott Laboratories Method and apparatus for reducing the size of an endoprosthesis
US20100010293A1 (en) * 2008-07-10 2010-01-14 Olympus Medical Systems Corp. Treatment method
US20100010514A1 (en) * 2008-07-11 2010-01-14 Olympus Medical Systems Corp. Tissue fastening tool
US20100010520A1 (en) * 2008-07-11 2010-01-14 Olympus Medical Systems Corp. Tissue fastener
US20120083820A1 (en) * 2009-04-22 2012-04-05 The Regents Of The University Of California Expandable distension device for hollow organ growth
US20120215236A1 (en) * 2010-06-22 2012-08-23 Olympus Medical Systems Corp. Tissue fastner production method and tissue fastener
US20130103166A1 (en) * 2011-04-13 2013-04-25 The Quality of Life Plus (QL+) Program Prosthetic Attachment Techniques
US20130013065A1 (en) * 2011-07-07 2013-01-10 Matthew Bills Tendon repair device and method

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10433847B2 (en) * 2013-12-17 2019-10-08 The Board Of Regents Of The University Of Nebraska Platform device and method of use to assist in anastomosis formation
US20220031326A1 (en) * 2013-12-17 2022-02-03 Board Of Regents Of The University Of Nebraska Platform Device and Method of Use to Assist in Anastomosis Formation
US11160555B2 (en) 2013-12-17 2021-11-02 Board Of Regents Of The University Of Nebraska Platform device and method of use to assist in anastomosis formation
US20170143469A1 (en) * 2014-06-25 2017-05-25 Assistance Publique - Hopitaux De Paris Removable implant for generating a tendon or a ligament
US11413132B2 (en) 2014-07-09 2022-08-16 Medos International Sarl Systems and methods for ligament graft preparation
US10357355B2 (en) 2014-07-09 2019-07-23 Medos International Sarl Systems and methods for ligament graft preparation
US9993332B2 (en) 2014-07-09 2018-06-12 Medos International Sarl Systems and methods for ligament graft preparation
US11864748B2 (en) 2015-04-23 2024-01-09 Depuy Synthes Products, Inc Knotless suture anchor guide
DE102015121374B4 (en) * 2015-12-08 2021-03-18 Otto-Von-Guericke-Universität Magdeburg Implant system comprising a feed unit and a clip for closing tubular anatomical structures
DE102015121374A1 (en) * 2015-12-08 2017-06-08 Otto-Von-Guericke-Universität Magdeburg Clip for the treatment of aneurysms and closure of tubular anatomical structures
US10383720B2 (en) 2015-12-22 2019-08-20 DePuy Synthes Products, Inc. Graft preparation system
US11395727B2 (en) 2015-12-22 2022-07-26 Medos International Sàrl Graft preparation system
US20210121181A1 (en) * 2017-07-26 2021-04-29 Neuraptive Therapeutics, Inc. Device and method of creating a fluid containment field for administering therapeutics to a nerve
US11633188B2 (en) * 2017-07-26 2023-04-25 Neuraptive Therapeutics, Inc. Device and method of creating a fluid containment field for administering therapeutics to a nerve
US20210338414A1 (en) * 2020-04-30 2021-11-04 Industrial Technology Research Institute Tissue repair device and method for using the same
US11850143B2 (en) * 2020-04-30 2023-12-26 Industrial Technology Research Institute Tissue repair device and method for using the same

Also Published As

Publication number Publication date
EP2931140A1 (en) 2015-10-21
EP2931140A4 (en) 2016-08-10
US20220054133A1 (en) 2022-02-24
WO2014092855A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
US20220054133A1 (en) Tissue repair devices and methods
JP6342449B2 (en) Indwelling suture material for eluting drug and method related thereto
JP5518737B2 (en) Indwelling suture with thermal contact mediator retainer
US11890003B2 (en) Indirect attachment of a needle to a mesh suture
EP3305211B1 (en) Improved suture
US20180360453A1 (en) Mesh suture
US20130013065A1 (en) Tendon repair device and method
BRPI0907787B1 (en) method for forming a self-retaining suture and apparatus for elevating the retainers in a suture to a desired angle
US20180070953A1 (en) Biodegradable blood vessel occlusion and narrowing
JP6802909B2 (en) Indirect attachment of the needle to the mesh suture
US20220347347A1 (en) Ligament Repair Scaffold
CA3038198A1 (en) Indirect attachment of a needle to a mesh suture

Legal Events

Date Code Title Description
AS Assignment

Owner name: NOVABIO TECHNOLOGIES, LLC, UTAH

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOLT, DOLLY JEANNE;REEL/FRAME:047059/0245

Effective date: 20180319

STCV Information on status: appeal procedure

Free format text: BOARD OF APPEALS DECISION RENDERED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCV Information on status: appeal procedure

Free format text: APPEAL BRIEF (OR SUPPLEMENTAL BRIEF) ENTERED AND FORWARDED TO EXAMINER

STCV Information on status: appeal procedure

Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS

STCV Information on status: appeal procedure

Free format text: BOARD OF APPEALS DECISION RENDERED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION